Newron Pharmaceuticals S.p.A. (NP5.DE)

EUR 8.8

(-0.34%)

Annual Balance Sheets

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 25.87 Million 37.19 Million 50.48 Million 51.19 Million 60.28 Million 59.73 Million
Total Current Assets 19.66 Million 28.49 Million 39.42 Million 37.87 Million 59.94 Million 59.51 Million
Cash And Short Term Investments 12.6 Million 22.77 Million 34.59 Million 31.25 Million 39.16 Million 43.85 Million
Cash and Cash Equivalents 6.34 Million 13.42 Million 25.01 Million 13.21 Million 22.05 Million 27.62 Million
Short Term Investments 6.26 Million 9.35 Million 9.57 Million 18.03 Million 17.11 Million 16.23 Million
Net Receivables 5.18 Million 4.95 Million 4.04 Million 5.75 Million 19.46 Million 15.43 Million
Inventory 1.00 762.39 Thousand 3850.00 846 Thousand -8.00 -15.43 Million
Other Current Assets 1.87 Million -1000.00 782.37 Thousand 22 Thousand 1.32 Million 15.65 Million
Total Non-Current Assets 6.21 Million 8.7 Million 11.05 Million 13.32 Million 342 Thousand 219 Thousand
Net PPE 405.19 Thousand 527 Thousand 577 Thousand 734 Thousand 252 Thousand 106 Thousand
Good Will And Intangible Assets - - 2000.00 11 Thousand 20 Thousand 30 Thousand
Good Will - - 1.59 - -0.01 -
Intangible Assets - - 1998.41 11 Thousand 20 Thousand 30 Thousand
Long-Term Investments 65.03 Thousand 73.83 Thousand 71.94 Thousand 64 Thousand 70 Thousand 83 Thousand
Tax Assets - - -71.94 Thousand -64 Thousand -70 Thousand -83 Thousand
Other Non Current Assets 5.74 Million 8.1 Million 10.48 Million 12.57 Million 70 Thousand 83 Thousand
Other Assets - - - - - -
Total Liabilities 55.8 Million 51.22 Million 47.37 Million 33.95 Million 23.49 Million 4.88 Million
Total Current Liabilities 28.94 Million 5.04 Million 3.65 Million 6.89 Million 5.59 Million 4.28 Million
Account Payables 2.01 Million 1.9 Million 1.5 Million 1.27 Million 2.4 Million 1.14 Million
Tax Payables - - - - - -
Short Term Debt 22.46 Million 172 Thousand 150 Thousand 151 Thousand 60 Thousand 151 Thousand
Deferred Revenue 1.00 - - - - -151 Thousand
Other Current Liabilities 4.45 Million 2.96 Million 2 Million 5.46 Million 3.12 Million 3.13 Million
Total Non Current Liabilities 26.86 Million 46.18 Million 43.72 Million 27.06 Million 17.89 Million 606 Thousand
Long-Term Debt 25.76 Million 45.49 Million 42.93 Million 26.19 Million 16.82 Million 125 Thousand
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.09 Million 694 Thousand 794 Thousand 866 Thousand 1.06 Million 481 Thousand
Other Liabilities - - - - - -
Total Equity -29.92 Million -14.03 Million 3.1 Million 17.24 Million 36.79 Million 54.84 Million
Stock Holders Equity -29.92 Million -14.03 Million 3.1 Million 17.24 Million 36.79 Million 54.84 Million
Common Stock 3.57 Million 3.56 Million 3.56 Million 3.56 Million 3.56 Million 3.56 Million
Retained Earnings -21.4 Million -22.8 Million -20.11 Million -26.15 Million -25.34 Million -20.19 Million
Accumulated other comprehensive income 15.21 Million 14.97 Million 14.54 Million 13.73 Million 12.26 Million -1.97 Million
Common Stock Equity -29.92 Million -14.03 Million 3.1 Million 17.24 Million 36.79 Million 54.84 Million
Capital Lease Obligation 210.1 Thousand 497 Thousand 539 Thousand 671 Thousand 138 Thousand 125 Thousand
Total Investments 6.32 Million 9.35 Million 9.57 Million 18.03 Million 17.11 Million 16.23 Million
Total Debt 48.43 Million 45.66 Million 43.08 Million 26.34 Million 16.88 Million 276 Thousand
Net Debt 42.09 Million 32.23 Million 18.06 Million 13.13 Million -5.16 Million -27.34 Million

Balance Sheet Charts